• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盆腔脏器清除术后的肠瘘和肠梗阻

Intestinal fistula and obstruction following pelvic exenteration.

作者信息

Lifshitz S, Johnson R, Roberts J A, Buchsbaum H J

出版信息

Surg Gynecol Obstet. 1981 May;152(5):630-2.

PMID:7221846
Abstract

Intestinal fistulas and obstruction are the most common and most serious complication of pelvic exenteration for gynecologic cancer. In a series of 58 patients, early intestinal fistulas developed in seven and late fistulas in 13 of the patients. Early fistulas are more commonly secondary to surgical trauma or technical errors and were noted to occur more frequently in patients who had previously undergone irradiation. Late fistulas are usually associated with intestinal obstruction and with a high incidence of recurrent malignant growth. The management of choice for intestinal fistulas following pelvic exenteration appears to be prompt surgical intervention with bypass procedures in preference to intestinal resections. Although several technical modifications have been applied to the exenterative operation with a trend toward a decrease in early obstruction and fistula formation rate, additional technical efforts will be necessary if these problems are to be solved.

摘要

肠瘘和肠梗阻是妇科癌症盆腔脏器清除术最常见、最严重的并发症。在一组58例患者中,7例出现早期肠瘘,13例出现晚期肠瘘。早期肠瘘更常见于手术创伤或技术失误,且在既往接受过放疗的患者中发生率更高。晚期肠瘘通常与肠梗阻及恶性肿瘤复发的高发生率相关。盆腔脏器清除术后肠瘘的首选治疗方法似乎是迅速进行手术干预并采用旁路手术,而非肠切除术。尽管已对脏器清除术进行了多项技术改进,早期肠梗阻和肠瘘形成率有下降趋势,但要解决这些问题仍需进一步的技术努力。

相似文献

1
Intestinal fistula and obstruction following pelvic exenteration.盆腔脏器清除术后的肠瘘和肠梗阻
Surg Gynecol Obstet. 1981 May;152(5):630-2.
2
Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990.盆腔脏器清除术后肠瘘的形成:对德克萨斯大学MD安德森癌症中心1957年至1990年经验的回顾
Gynecol Oncol. 1995 Feb;56(2):207-10. doi: 10.1006/gyno.1995.1033.
3
Small bowel bypass for complications related to pelvic malignancy.针对与盆腔恶性肿瘤相关并发症的小肠旁路手术。
Obstet Gynecol. 1973 Nov;42(5):661-6.
4
Intestinal fistulas following pelvic exenteration.盆腔脏器清除术后的肠瘘
Surg Gynecol Obstet. 1966 Nov;123(5):991-4.
5
Pelvic floor reconstruction following gynecologic exenterative surgery.妇科广泛性手术术后盆底重建
Obstet Gynecol. 1977 Jul;50(1):31-4.
6
Use of a saline breast implant to cover the pelvic floor.
Gynecol Oncol. 1997 Apr;65(1):188-91. doi: 10.1006/gyno.1997.4641.
7
Management of the pelvic floor after pelvic exenteration.盆腔脏器切除术后盆底的管理。
Obstet Gynecol. 1977 Aug;50(2):166-71.
8
Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis.根治性盆腔手术后低位结直肠吻合术:危险因素分析
Am J Obstet Gynecol. 2000 Dec;183(6):1375-9; discussion 1379-80. doi: 10.1067/mob.2000.110908.
9
[Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].[晚期妇科恶性肿瘤的盆腔脏器清除术:18例报告]
Zhonghua Fu Chan Ke Za Zhi. 2000 May;35(5):288-90.
10
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.复发性妇科恶性肿瘤行盆腔脏器清除术患者的可控性尿流改道术及低位直肠吻合术。
Gynecol Oncol. 2000 Aug;78(2):208-11. doi: 10.1006/gyno.2000.5864.

引用本文的文献

1
Management of enteroperineal fistulas following pelvic exenteration: Insights from a high-volume referral centre.盆腔脏器清除术后肠会阴瘘的管理:来自一家高容量转诊中心的见解
Colorectal Dis. 2025 May;27(5):e70085. doi: 10.1111/codi.70085.
2
CT findings after pelvic exenteration: review of normal appearances and most common complications.盆腔廓清术后的 CT 表现:正常表现及常见并发症回顾。
Radiol Med. 2019 Jul;124(7):693-703. doi: 10.1007/s11547-019-01009-9. Epub 2019 Feb 26.
3
Risk of small bowel obstruction after the ileal pouch-anal anastomosis.
回肠储袋肛管吻合术后小肠梗阻的风险。
Ann Surg. 2002 Feb;235(2):200-6. doi: 10.1097/00000658-200202000-00007.